Join
Live feed
·
INSIDERFilingvia Quantisnow
Clovis Oncology Inc. logo

SEC Form 4: Ivers-Read Gillian C sold $16,817 worth of shares (3,696 units at $4.55) and converted options into 8,374 shares, increasing direct ownership by 2% to 259,658 units (for withholding tax)

ByQuantisnow·Wall Street's wire, on your screen.

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track CLVS (Clovis Oncology Inc.) and more on Quantisnow.

SEC Form 4: Ivers-Read Gillian C sold $16,817 worth of shares (3,696 units at $4.55) and converted options into 8,374 shares, increasing direct ownership by 2% to 259,658 units (for withholding tax) | Quantisnow